4.5 Article

Triclocarban enhances testosterone action: A new type of endocrine disruptor?

Journal

ENDOCRINOLOGY
Volume 149, Issue 3, Pages 1173-1179

Publisher

ENDOCRINE SOC
DOI: 10.1210/en.2007-1057

Keywords

-

Funding

  1. NCRR NIH HHS [P51 RR000169] Funding Source: Medline
  2. NIEHS NIH HHS [P42 ES004699, P01ES06198, P30 ES005707, P01 ES006198, R37ES02710, P30ES005707, R37 ES002710, P42ES04699] Funding Source: Medline

Ask authors/readers for more resources

Many xenobiotics have been associated with endocrine effects in a wide range of biological systems. These associations are usually between small nonsteroid molecules and steroid receptor signaling systems. In this report, triclocarban (TCC; 3,4,4'-trichlorocarbanilide), a common ingredient in personal care products that is used as an antimicrobial agent was evaluated and found to represent a new category of endocrine-disrupting substance. A cell-based androgen receptor-mediated bioassay was used to demonstrate that TCC and other urea compounds with a similar structure, which have little or no endocrine activity when tested alone, act to enhance testosterone (T)-induced androgen receptor-mediated transcriptional activity in vitro. This amplification effect of TCC was also apparent in vivo when 0.25% TCC was added to the diet of castrated male rats that were supported by exogenous testosterone treatment for 10 d. All male sex accessory organs increased significantly in size after the T+TCC treatment, compared with T or TCC treatments alone. The data presented here suggest that the bioactivity of endogenous hormones may be amplified by exposure to commercial personal care products containing sufficient levels of TCC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available